Page 2 - Depression Scale News Today

Symptoms of anxiety and depression were highly prevalent among patients with IA and were associated with low self-management behaviors.

A Japanese study of alopecia areata (AA) found misalignment between patient and doctor perceptions of severity, limiting treatment options, and leading to dissatisfaction and unmet needs.

These data on the success of twice-daily, 5 and 10 mg doses of tofacitinib may help inform clinicians in their practice as well as the health community in general.

Researchers investigated chronic critical illness in COVID-19 survivors who sought ICU admission and were on mechanical ventilation due to severe infection by SARS-CoV-2.

Naturally occurring variations in appointment frequencies do not appear to have a major impact on clinical outcomes, but they significantly affect waiting times.

Compared with patients with only chronic obstructive pulmonary disease (COPD), patients with COPD and anxiety and/or depression had increased clinical and economic burden.

Our January 2024 psychiatry month in review includes studies finding associations with depression, anxiety, and anorexia nervosa, as well as a phase 3 study looking into long-term safety of olanzapine, samidorphan.

A study found when older adults follow a light-moderate or a vigorous physical activity model it is associated with a lower incidence rate ratio of depression.

People with alopecia areata who experience hair regrowth may also see improvements in their quality of life and mental health, according to a new study.

The effects of six months of multi-level workplace interventions aimed at decreasing sedentary behavior.